Yamagishi Yukiko, Ueno Motoi, Ueno Chihoko, Kato Akemi, Kanasaki Ryuichi, Sato Bunji, Takakura Koji, Fujie Akihiko, Nakajima Hidenori, Fujii Takashi, Hino Motohiro, Tsujii Eisaku
Fermentation Research Labs, Astellas Pharma Inc., Tsukuba-shi, Ibaraki, Japan.
J Antibiot (Tokyo). 2009 Feb;62(2):95-8. doi: 10.1038/ja.2008.18. Epub 2009 Jan 23.
In the previous study, we discovered a polyether antibiotic CP-44161, which was reported earlier as an anticoccidal agent, as an anti-varicella zoster virus compound. In this study, we demonstrated that CP-44161 had a very strong and broad anti-herpes virus activities against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. To determine the antiviral activity of CP-44161 in vivo, we examined its effect on the cutaneous HSV-2 infection model in Balb/c mice. CP-44161 showed inhibitory effect on lesion development as well as acyclovir (ACV) when the treatment was started from day 3. Meanwhile, in case the start of treatment was delayed until day 4, when ACV was no longer effective, the effectiveness of CP-44161 still remained. In this model, CP-44161 also showed inhibitory effect on the proliferation of HSV-2 DNA in dorsal root ganglia. This is the first article to report that polyether antibiotics can be effective on viral infection in vivo.
在之前的研究中,我们发现了一种聚醚抗生素CP - 44161,它之前被报道为一种抗球虫剂,而我们发现它是一种抗水痘带状疱疹病毒化合物。在本研究中,我们证明CP - 44161在体外对1型单纯疱疹病毒(HSV - 1)和2型单纯疱疹病毒(HSV - 2)具有非常强且广泛的抗疱疹病毒活性。为了确定CP - 44161在体内的抗病毒活性,我们检测了其对Balb/c小鼠皮肤HSV - 2感染模型的影响。当从第3天开始治疗时,CP - 44161对病变发展显示出抑制作用,与阿昔洛韦(ACV)的效果相当。同时,如果治疗开始延迟到第4天,此时阿昔洛韦不再有效,CP - 44161的有效性仍然存在。在这个模型中,CP - 44161对背根神经节中HSV - 2 DNA的增殖也显示出抑制作用。这是第一篇报道聚醚抗生素对体内病毒感染有效的文章。